RTO

RTO Financing Cash Flow

-$845.10MTTM · USD

Period ending:

RTO FY Cash from FinancingUSD
RTO FY Cash from Financing1991-12-31: $13.95M1992-12-31: $3.60M1993-12-31: -$22.00M1994-12-31: $19.30M1995-12-31: $46.40M1996-12-31: $247.00M1997-12-31: $11.80M1998-12-31: -$167.20M1999-12-31: $600.00K2000-12-31: -$667.70M2001-12-31: -$58.00M2002-12-31: $55.00M2003-12-31: -$95.60M2004-12-31: -$356.20M2005-12-31: -$240.10M2006-12-31: $65.40M2007-12-31: -$464.65M2008-12-31: $117.78M2009-12-31: -$220.81M2010-12-31: -$132.90M2011-12-31: -$42.70M2012-12-31: $153.00M2013-12-31: -$97.00M2014-12-31: -$204.00M2015-12-31: $123.90M2016-12-31: -$66.90M2017-12-31: -$164.60M2018-12-31: -$115.70M2019-12-31: -$221.30M2020-12-31: $229.00M2021-12-31: -$417.10M2022-12-31: $1.32B2023-12-31: -$361.00M2024-12-31: -$752.00M2025-12-31: $27.03M$1.32B-$752.00M
1991-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RTO financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 35 observations from Dec 31, 1991 to Dec 31, 2025.

Rentokil Initial plc American Depositary Shares (each representing five (5) Ordinary Shares) Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
27,025,367
-752,000,000
-361,000,000
1,323,000,000
-417,100,000
229,000,000
-221,300,000
-115,700,000
-164,600,000
-66,900,000
123,900,000
-204,000,000
-97,000,000
153,000,000
-42,700,000
-132,900,000
-220,810,504
117,776,371
-464,654,363
65,400,000
-240,100,000
-356,200,000
-95,600,000
55,000,000
-58,000,000
-667,700,000
600,000
-167,200,000
11,800,000
247,000,000
46,400,000
19,300,000
-22,000,000
3,600,000
13,945,000

Compare financing cash flow

All RTO financial metrics · RTO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.